Physician

Jill Perry Trumble, MD

According to 2025 Medicare claims, Jill Trumble, MD (NPI: 1437311180) practices neurology in the Savannah, GA market, with the plurality of this provider's patient population coming from Chatham, GA. This provider's primary affiliated billing organization is SJC MEDICAL GROUP INC (NPI: 1811233828; TIN: 58-2011805) and primary practice location at 31419-1751. Trumble is affiliated with the Main Street Rural Health Juniper ACO LLC (ACO ID: A5399), participating under the MSSP model.

Trumble's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,006 traditional Medicare patients, billed 37,159 HCPCS/CPT codes, and received $322,268 in Medicare payments. The top billing code was 99483 (Assessment of and care planning for patient with impaired thought processing, typically 60 minutes). Part D data shows 8,026 prescription claims across 1,154 beneficiaries totaling $2,231,965 in drug costs, led by Ingrezza (Valbenazine Tosylate). 2022 DME data shows 16 claims. Open Payments data shows 50 records totaling $1,056. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $155,912 to $322,268. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and rose steadily, from $2,169 to $5,216.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	628	8,292	$155,912
2016	748	11,654	$167,163
2017	877	22,093	$231,335
2018	993	30,929	$292,123
2019	1,009	31,173	$292,183
2020	962	38,999	$326,145
2021	964	45,531	$382,024
2022	928	40,388	$338,535
2023	917	37,918	$312,896
2024	1,006	37,159	$322,268

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	427	4,013	$1,737,019
2016	564	5,525	$2,711,992
2017	659	6,117	$2,646,267
2018	765	6,502	$2,439,168
2019	807	6,866	$1,708,867
2020	873	7,110	$1,732,485
2021	954	7,245	$2,161,729
2022	992	7,509	$2,359,324
2023	1,043	7,555	$2,401,222
2024	1,154	8,026	$2,231,965

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$153
2016	N/R	14	$124
2017	N/R	N/R	N/R
2018	N/R	13	$122
2019	N/R	11	$239
2020	N/R	36	$5,794
2021	N/R	17	$2,025
2022	N/R	16	$628
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99483	Assessment of and care planning for patient with impaired thought processing, typically 60 minutes	58	58	$190
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	182	182	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	575	803	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	252	264	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	231	234	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ingrezza	Valbenazine Tosylate	61	1,820	$516,815
Nourianz	Istradefylline	110	4,740	$291,554
Rytary	Carbidopa/Levodopa	141	7,023	$217,801
Nuplazid	Pimavanserin Tartrate	32	1,260	$208,080
Qulipta	Atogepant	73	3,030	$113,480

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$1,056	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jill Perry Trumble, MD?

Tedicare shows public-source Medicare data for Jill Perry Trumble, MD (NPI 1437311180), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jill Perry Trumble, MD have ACO affiliation data?

Jill Perry Trumble, MD is shown with ACO affiliation data for Main Street Rural Health Juniper ACO LLC (MSSP, ACO ID A5399).

What billing organization is linked to Jill Perry Trumble, MD?

Jill Perry Trumble, MD is linked to SJC MEDICAL GROUP INC (billing NPI 1811233828) in the available physician profile data.

Does Jill Perry Trumble, MD have Open Payments data?

Jill Perry Trumble, MD has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.